STAR and metabolic dysfunction-associated steatotic liver disease: Previous work has demonstrated that STAR overexpression in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice decreased intracellular DAG levels, indicating a protective role for STAR in NAFLD through a reduction in DAG levels [23].